Key Financial Inc’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.2K Hold
244
0.01% 566
2025
Q4
$41.2K Hold
244
0.01% 561
2025
Q3
$36.2K Sell
244
-28
-10% -$3.82K 0.01% 586
2025
Q2
$34.4K Buy
272
+52
+24% +$6.38K 0.01% 572
2025
Q1
$28.1K Hold
220
0.01% 586
2024
Q4
$29.1K Hold
220
0.01% 574
2024
Q3
$32K Sell
220
-30
-12% -$4.34K 0.01% 560
2024
Q2
$34.3K Buy
250
+30
+14% +$4K 0.01% 531
2024
Q1
$30.2K Sell
220
-70
-24% -$9.56K 0.01% 531
2023
Q4
$39.4K Buy
290
+70
+32% +$8.54K 0.01% 465
2023
Q3
$26.9K Buy
220
+12
+6% +$1.53K 0.01% 504
2023
Q2
$26.4K Hold
208
0.01% 519
2023
Q1
$26.9K Sell
208
-1,037
-83% -$136K 0.01% 484
2022
Q4
$146K Hold
1,245
0.07% 198
2022
Q3
$146K Hold
1,245
0.07% 200
2022
Q2
$150K Hold
1,245
0.08% 188
2022
Q1
$162K Buy
1,245
+1,000
+408% +$130K 0.08% 192
2021
Q4
$37K Buy
245
+50
+26% +$7.74K 0.02% 388
2021
Q3
$32K Hold
195
0.02% 397
2021
Q2
$32K Hold
195
0.02% 406
2021
Q1
$29K Hold
195
0.02% 347
2020
Q4
$30K Buy
+195
New +$27.9K 0.02% 321
2020
Q2
Sell
-195
Closed -$21K 332
2020
Q1
$21K Buy
+195
New +$22.5K 0.02% 316

Other funds holding IBB

Key Financial Inc's IBB Position: Q1 2026 in Review

Key Financial Inc held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 244 shares worth $41.2K. The position accounts for 0.01% of the portfolio, ranked #566.

Key Financial Inc first reported a position in IBB in Q1 2020 and has held it in 23 quarters since. The position peaked at $162K in Q1 2022. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Key Financial Inc held 244 shares of iShares Biotechnology ETF worth $41.2K as of Q1 2026.
  • Key Financial Inc left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up 0.01% of Key Financial Inc's portfolio in Q1 2026, its #566 holding.
  • Key Financial Inc first reported a position in iShares Biotechnology ETF in Q1 2020 and has held it in 23 quarters since.
  • Key Financial Inc's iShares Biotechnology ETF position peaked at $162K in Q1 2022.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Key Financial Inc's 13F filing for Q1 2026, filed 24 Apr 2026.